Paul P Dobesh

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Topics

Systematic Review

Direct Oral Anticoagulants

Cardiovascular Disease

Top Venues

Pharmacotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

C Michael White, Kimberly Snow Caroti, Youssef Bessada, Adrian V Hernández, William L Baker, Paul P Dobesh, Heleen van Haalen, Kirsty M Rhodes, Craig I Coleman
Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta-analysis. Pharmacotherapy (2024)
C Michael White, Kimberly Snow Caroti, Youssef Bessada, Adrian V Hernández, William L Baker, Paul P Dobesh, Heleen van Haalen, Kirsty M Rhodes, Craig I Coleman
Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta-analysis. Pharmacotherapy 44 (5) (2024)
C Michael White, Kimberly Snow Caroti, Youssef Bessada, Adrian V Hernández, William L Baker, Paul P Dobesh, Heleen van Haalen, Kirsty M Rhodes, Craig I Coleman
Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta-analysis. Pharmacotherapy 44 (5) (2024)
Paul P Dobesh, Andrew M Goldsweig
Antithrombotic Therapy with Transcatheter Aortic Valve Replacement. Pharmacotherapy (2023)
Paul P Dobesh, Toby C Trujillo
Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID-19. Pharmacotherapy 40 (11) (2020)
Toby C Trujillo, Paul P Dobesh, George H Crossley, Shannon W Finks
Contemporary Management of Direct Oral Anticoagulants During Cardioversion and Ablation for Nonvalvular Atrial Fibrillation. Pharmacotherapy 39 (1) (2019)
Brandon Cave, Augustus Hough, Paul P Dobesh
Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients. Pharmacotherapy 38 (6) (2018)